In view of the core enterprises in the supply chain and their trading relationships with upstream and downstream supporting enterprises, supply chain finance companies provide pledge financing for accounts payable, accounts receivable and inventory of upstream and downstream small and medium-sized enterprises with the help of large enterprises' payment ability evaluation and strong credit support, and provide comprehensive financial service support for single or multiple pharmaceutical enterprises in the supply chain, effectively solving the problem of fund gap and credit imbalance of supply chain enterprises. Then, the following is the cooperation model between pharmaceutical companies and supply chain finance that I have compiled for you. Welcome to read and browse.
(1) Demand for financial service products in upstream procurement supply chain of pharmaceutical industry. According to the characteristics of the procurement link in the pharmaceutical industry chain, domestic factoring and accounts receivable pledge business are recommended for financial products in the procurement link.
1, domestic factoring business
(1) Business definition: It means that the upstream supplier sells the accounts receivable to the core enterprise (pharmaceutical manufacturer) on credit, and the supply chain finance company receives the accounts receivable, and on this basis, it provides the supplier with a series of comprehensive financial services such as accounts receivable account management, accounts receivable financing, accounts receivable collection, and undertaking the credit risk of the accounts receivable buyer.
(2) Applicability: The upstream suppliers (production or trading enterprises) of the core enterprises have certain financial strength, and can produce or purchase with their own funds and sell them to the core enterprises on credit.
(3) Risk points and control measures: In order to protect the rights and interests of supply chain finance companies under accounts receivable, before the business comes out of the cabinet, it should be inquired and registered on the accounts receivable pledge registration publicity system of People's Supply Chain Finance Company, in order to fight against bona fide third parties and obtain the priority of compensation.
2. Domestic accounts receivable pledge credit business
(1) business definition: refers to the credit line of supply chain finance companies obtained by upstream suppliers selling accounts receivable to core enterprises (pharmaceutical manufacturing enterprises) and pledging related accounts receivable to supply chain finance companies and their specific financing businesses. Accounts receivable pledge credit business takes accounts receivable payment as the main repayment source, and supply chain finance companies reserve the right of financing recourse against credit applicants (i.e. upstream suppliers).
(2) Applicability: The upstream suppliers (production or trading enterprises) of the core enterprises have certain financial strength, and can produce or purchase with their own funds and sell them to the core enterprises on credit.
(3) Risk control measures: Before the business comes out of the cabinet, it should be inquired and registered in the public notice system of accounts receivable pledge registration of People's Supply Chain Finance Company, so as to fight against bona fide third parties and obtain priority creditor's rights.
(2) Demand for downstream sales of related products in pharmaceutical industry.
3. Confirmed warehouse business
(1) Business background: Warehouse-keeping business is a financing scheme provided by supply chain finance companies for the downstream customers of pharmaceutical manufacturers in the pharmaceutical supply chain (these downstream customers are mainly drug distributors and agents outside hospitals, hereinafter referred to as pharmaceutical companies), because they have a payment period from the purchase of drugs by core enterprises to the receipt of sales funds, and lack short-term liquidity.
(2) Business definition: Supply chain finance companies sign tripartite business cooperation agreements with core enterprises (pharmaceutical manufacturers) and pharmaceutical companies, allowing pharmaceutical companies to take delivery of goods by cash and acceptance bills or domestic letters of credit through supply chain finance companies, and the core enterprises are entrusted with the custody of drugs. After the pharmaceutical company applies for payment to the supply chain finance company, the supply chain finance company informs the core enterprise to deliver the goods, and the core enterprise delivers the goods according to the instructions of the supply chain finance company.
(3) Applicability: Pharmaceutical companies should be recognized by core enterprises and recommended to supply chain finance companies; The core enterprise is willing to assist the supply chain finance company to control the goods and bear the responsibility of refund of the price difference (undelivered part).
(4) Key points of operation: The core enterprises should be explicitly required in the tripartite cooperation agreement to bear the responsibility of difference return or joint guarantee to the supply chain finance company; The financing funds of supply chain finance companies should be paid to the core enterprises, and the acceptance bills of supply chain finance companies should be delivered directly to the core enterprises.
(5) Business process: ① Supply chain finance companies and core enterprises sign a general cooperation agreement for supply chain financial service outlets; ② Supply chain finance companies, core enterprises and pharmaceutical companies sign tripartite business cooperation agreements; (3) The pharmaceutical company applies to the supply chain finance company to open a supply chain finance company acceptance bill (or demand loan, domestic letter of credit, etc.). ); (4) Supply chain finance companies make directional payments to core enterprises; ⑤ Pharmaceutical companies pay supply chain finance companies to apply for delivery; ⑥ The supply chain finance company informs the core enterprise to deliver the goods; (7) When the core enterprise delivers the goods to the pharmaceutical companies (note: repeat this operation until the delivery is completed), the pharmaceutical companies shall deposit sufficient deposit with the supply chain finance company before the acceptance bill or tripartite agreement expires, so as to fill the financing exposure at the same time; (8) If the pharmaceutical company breaches the contract (fails to pay the payment within the agreed time), the supply chain finance company shall notify the core enterprise to return the unpaid part to the supply chain finance company.
4. Manufacturer's banking business
(1) business background: similar to warehouse keeping business.
(2) Business definition: The operation of manufacturer's banking business is similar to warehouse keeping business, which means that supply chain finance companies sign tripartite business cooperation agreements with core enterprises (pharmaceutical production enterprises) and pharmaceutical companies (pharmaceutical circulation enterprises, etc.). ) Provide financing for pharmaceutical companies to meet their capital demand for ordering drugs and medical devices from core enterprises, and core enterprises provide joint liability guarantee for pharmaceutical companies to supply chain finance companies. The difference between it and the warehouse keeping business is that the banking business of the manufacturer cannot be operated in the same cycle as the warehouse keeping business.
(3) Applicability: Pharmaceutical companies are closely related to core enterprises, such as sales molecular companies established by pharmaceutical companies for core enterprises in various places; Pharmaceutical companies should be recognized by core enterprises and recommended to supply chain finance companies; Core enterprises are willing to bear joint and several liabilities to supply chain finance companies.
(4) Key points of risk control: Core enterprises should sign guarantee contracts with supply chain finance companies, and clearly assume joint and several guarantee responsibilities for pharmaceutical companies in supply chain finance companies.
(5) Business process: ① Supply chain finance companies and core enterprises sign general cooperation agreements and guarantee contracts for supply chain financial service outlets; ② Supply chain finance companies, core enterprises and pharmaceutical companies sign tripartite business cooperation agreements; (3) The pharmaceutical company applies to the supply chain finance company to open a supply chain finance company acceptance bill (or demand loan, domestic letter of credit, etc.). ); (4) Supply chain finance companies make directional payments to core enterprises; (5) Core enterprises deliver goods to pharmaceutical companies on their own according to the production and marketing progress; ⑥ If the pharmaceutical company breaches the contract, the supply chain finance company will notify the core enterprise to undertake joint and several liability guarantee and make relevant compensation to the supply chain finance company.
5. Order financing
(1) Business background: For pharmaceutical enterprises with good qualifications, stable supply and marketing channels, or affiliated companies as the core enterprises, if their downstream enterprises are hospitals in a strong position, hospitals are unwilling to apply for financing services from supply chain finance companies or confirm the accounts receivable of pharmaceutical enterprises when purchasing drugs and medical devices from pharmaceutical enterprises in bulk. Supply chain finance companies can provide financing for pharmaceutical enterprises.
(2) Business definition: refers to the business in which an enterprise provides a special loan for purchasing materials and organizing production for the enterprise on the basis of a buyer's product order with good credit under the conditions of mature technology, guaranteed production capacity and effective guarantee, and the enterprise immediately repays the loan after receiving the payment.
(3) Business process: ① The pharmaceutical company issues a letter of commitment to the supply chain finance company, stipulating that its collection account is a supervision account; (2) When a hospital signs a purchase agreement with a pharmaceutical company, the pharmaceutical company applies to the supply chain finance company for financing based on the original agreement, and the supply chain finance company reviews the purchase agreement; (3) The supply chain finance company makes directional payment to the core enterprise, and gives the current loan or unexpired acceptance bill to the core enterprise supply chain finance company according to the purchase contract of the pharmaceutical company; (4) After receiving the payment, the core enterprise delivers the goods through the logistics company designated by the supply chain finance company; ⑤ After receiving the drugs or medical devices, the hospital will transfer the money to the supervision account of the supply chain finance company according to the collection account number on the purchase contract.
(4) Risk point control: When signing the purchase agreement with the hospital, the pharmaceutical company agrees to lock the payment account in the supply chain finance company; The pharmaceutical company is required to issue a letter of commitment to the supply chain finance company: all sales receipts of the company will be returned to the supply chain finance company account, and the supply chain finance company will supervise the receipt account; The supply chain finance company signed a notification letter with the pharmaceutical company * * * to inform the hospital that the pharmaceutical company has applied for financing from the supply chain finance company, and the hospital must transfer the payment to the account of the supply chain finance company according to the order and purchase agreement; Drug manufacturers must deliver the goods through the logistics company designated by the supply chain finance company, and the logistics company monitors the transportation process of drugs and medical devices throughout the process.
6, domestic commercial invoice discount
(1) Business background: Commercial invoice discount business is aimed at Chinese medicine enterprises in the pharmaceutical supply chain by supply chain finance companies. Because their downstream customers (such as hospitals) are relatively strong, most of them buy drugs and medical devices on credit. Pharmaceutical companies sell drugs to downstream customers, receive sales money, have a repayment period, and lack short-term liquidity.
(2) Business definition: Domestic commercial invoice discount refers to a contract between a supply chain finance company and a seller. According to this contract, the seller will transfer the accounts receivable arising from the current or future contract for the sale of goods with the buyer (debtor) to the supply chain finance company, which will provide the seller with comprehensive financial services such as trade financing, sales ledger management and accounts receivable collection. This business is also a kind of domestic factoring business, based on the transfer of accounts receivable creditor's rights.
The seller can apply for financing from the supply chain finance company with the commercial invoice to be discounted, the original and photocopy of the value-added tax invoice with the creditor's rights transfer statement and other relevant commercial documents and vouchers.
(3) Business applicable to customers and merchants: small and medium-sized enterprises that have cooperated with supply chain finance companies for a certain number of years, have stable operations, need to realize sales repayment as soon as possible, and require rapid capital turnover; Widely used in credit sales, collection and other trading methods.
(4) Business process: ① The pharmaceutical company and the supply chain finance company sign a domestic commercial invoice discount agreement; (2) Pharmaceutical enterprises sell medical consumables or provide services to downstream enterprises; ③ Downstream enterprises notify pharmaceutical companies to open commercial invoices; (4) The supply chain finance company discounts the seller's commercial invoice according to the provisions of the discount agreement, and at the same time, the pharmaceutical company conveys the notice of transfer of accounts receivable to the buyer; ⑤ Supply chain finance companies take appropriate measures to recover accounts receivable from the buyer before the due date; ⑥ If the buyer's payment is not received on the due date of the discounted commercial invoice, the supply chain finance company has the right to recover the discounted amount from the pharmaceutical company 30 days after the due date of the relevant commercial invoice and bear reasonable interest. When the buyer pays due, the supply chain finance company will repay the discounted principal and interest and transfer the balance to the seller.
(5) Risk control: Before discounting invoices to pharmaceutical companies, supply chain finance companies need to strictly examine their operating conditions and future cash flows; Choose downstream customers with better qualifications; Supply chain finance companies need to urge buyers to collect money before accounts receivable expire; Once downstream customers are found unable to pay or inclined to refuse to pay, measures should be taken immediately to ensure that the credit funds of supply chain finance companies can be recovered on time.
7. Pledge of accounts receivable
(1) Business background: The financing scheme provided by the supply chain finance company is aimed at the short-term liquidity shortage when Chinese medicine enterprises or pharmaceutical production enterprises sell goods to downstream enterprises in the pharmaceutical supply chain.
(2) Business definition and operation flow: consistent with the financing method of raw material suppliers of core enterprises in the procurement stage.
;